Restoration of Disturbed Intracortical Motor Inhibition and Facilitation in Attention Deficit Hyperactivity Disorder Children by Methylphenidate

Biological Psychiatry

Volumn 62, Issue 9, 2007, Pages 963-969

  Buchmann, Johannes ^a   Gierow, Wolfgang ^a   Weber, Simone ^a   Hoeppner, Jacqueline ^a   Klauer, Thomas ^a   Benecke, Reiner ^a   Haessler, Frank ^a   Wolters, Alexander ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

ADHD; methylphenidate; motorcortical facilitation; motorcortical inhibition; paired pulse; transcranial magnetic stimulation

Indexed keywords

METHYLPHENIDATE;

ANALYSIS OF VARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; CLINICAL ARTICLE; CORRELATION ANALYSIS; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MOTOR ACTIVITY; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MOTOR CORTEX; NEURAL INHIBITION; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 35248884019     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.05.010     Document Type: Article

References (71)

1. Buchmann J., Wolters A., Haessler F., Bohne S., Nordbeck R., and Kunesch E. Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD). Clin Neurophysiol 114 (2003) 2036-2042
2. Buchmann J., Gierow W., Weber S., Hoeppner J., Klauer T., Wittstock M., Benecke R., et al. Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH). Neurosci Lett 405 (2006) 14-18
3. Moll G.H., Heinrich H., Trott G., Wirth S., and Rothenberger A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 284 (2000) 121-125
4. Valls-Sole J., Pascual-Leone A., Wassermann E.M., and Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 85 (1992) 355-364
5. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., et al. Corticocortical inhibition in human motor cortex. J Physiol 471 (1993) 501-519
6. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res 154 (2004) 1-10
7. Moll G.H., Heinrich H., Wischer S., Tergau F., Paulus W., and Rothenberger A. Motor system excitability in healthy children: Developmental aspects from transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol Suppl 51 (1999) 243-249
8. Mall V., Berweck S., Fietzek U.M., Glocker F.X., Oberhuber U., Walther M., Schessl J., et al. Low level of intracortical inhibition in children shown by transcranial magnetic stimulation. Neuropediatrics 35 (2004) 120-125
9. Gilbert D.L., Sallee F.R., Zhang J., Lipps T.D., and Wassermann E.M. Transcranial magnetic stimulation-evoked cortical inhibition: A consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome. Biol Psychiatry 57 (2005) 1597-1600
10. Moll G.H., Heinrich H., Trott G.E., Wirth S., Bock N., and Rothenberger A. Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: Evidence for additive inhibitory deficits within the motor system. Ann Neurol 49 (2001) 393-396
11. Gilbert D.L., Wang Z., Sallee F.R., Ridel K.R., Merhar S., Zhang J., Lipps T.D., et al. Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain 129 (2006) 2038-2046
12. Gilbert D.L., Bansal A.S., Sethuraman G., Sallee F.R., Zhang J., Lipps T., and Wassermann E.M. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord 19 (2004) 416-425
13. Greenberg B.D., Ziemann U., Cora-Locatelli G., Harmon A., Murphy D.L., Keel J.C., and Wassermann E.M. Altered cortical excitability in obsessive-compulsive disorder. Neurology 54 (2000) 142-147
14. Elia J., Ambrosini P.J., and Rapoport J.L. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340 (1999) 780-788
15. Greenhill L.L., Findling R.L., and Swanson J.M. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 109 (2002) E39
16. Greenhill L.L., Swanson J.M., Vitiello B., Davies M., Clevenger W., Wu M., Arnold L.E., et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. J Am Acad Child Adolesc Psychiatry 40 (2001) 180-187
17. Gilbert D.L., Ridel K.R., Sallee F.R., Zhang J., Lipps T.D., and Wassermann E.M. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 31 (2006) 442-449
18. Tewes U., Rossmann P., and Schallberger U. Hamburg-Wechsler-Intelligenztest für Kinder III (HAWIK III) (2000), Huber, Bern
19. Melchers P., and Preuss U. Kaufmann-Assessment Battery for Children (K-ABC; deutschsprachige Fassung) (1994), Swets & Zeitlinger, Amsterdam
20. Achenbach T.M. Empirically Based Taxonomy: How to use Syndromes and Profile Types Derived from the CBCL-4-18, TRF and YSR (1993), University of Vermont, Burlington
21. Döpfner M., Melchers P., and Fegert J.M. Deutschsprachige Konsensusversionen der Child Behavior Checklist (CBCL 4-18), der Teacher Report Form (TRF) und der Youth Self Report Form (YSR). Kindh Entwickl 3 (1994) 54-59
22. Döpfner M., Plück J., Bölte S., Lenz K., Melchers P., and Heim K. Deutsche Bearbeitung der Child Behavior Check List (CBCL/4-18) (1998), KJFD, Köln
23. Döpfner M., Frölich J., and Lehmkuhl G. Hyperkinetische Störungen. Leitfaden Kinder- und Jugendpsychiatrie (2000), Hogrefe, Göttingen
24. Döpfner M., and Lehmkuhl G. DISYPS-KJ Manual. Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV (2000), Bern, Göttingen, Toronto, Seattle, Verlag Hans Huber
25. Conners C.K. The Conners′ continuous performance test manual (1995), Multi-Health-Systems, Toronto
26. Conners C.K. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Am 46 (1999) 857-870 vi
27. Brickenkamp R. Aufmerksamkeits-Belastungs-Test d2 (2002), Hogrefe, Göttingen
28. Koch I., and Pleizner S. Konzentrations - Handlungs - Verfahren (1984), Psychodiagnostisches Zentrum, Sektion Psychologie der Humbold Universit at Berlin, Berlin
29. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., Dimitrijevic M.R., et al. Noninvasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91 (1994) 79-92
30. Kiers L., Cros D., Chiappa K.H., and Fang J. Variability of motor potentials evoked by transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 89 (1993) 415-423
31. Garvey M.A., and Gilbert D.L. Transcranial magnetic stimulation in children. Eur J Paediatr Neurol 8 (2004) 7-19
32. Gilbert D.L., Garvey M.A., Bansal A.S., Lipps T., Zhang J., and Wassermann E.M. Should transcranial magnetic stimulation research in children be considered minimal risk?. Clin Neurophysiol 115 (2004) 1730-1739
33. Moll G.H., Heinrich H., and Rothenberger A. Transcranial magnetic stimulation in child and adolescent psychiatry: Excitability of the motor cortex system in tic disorders and/or attention deficit hyperactivity disorders. Z Kinder Jugendpsychiatr Psychother 29 (2001) 312-323
34. Garvey M.A., Barker C.A., Bartko J.J., Denckla M.B., Wassermann E.M., Castellanos F.X., Dell M.L., et al. The ipsilateral silent period in boys with attention-deficit/hyperactivity disorder. Clin Neurophysiol 116 (2005) 1889-1896
35. Kirschner J., Moll G.H., Fietzek U.M., Heinrich H., Mall V., Berweck S., Heinen F., et al. Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry 36 (2003) 79-82
36. Moll G.H., Heinrich H., and Rothenberger A. Methylphenidate and intracortical excitability: Opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr Scand 107 (2003) 69-72
37. Ziemann U., Paulus W., and Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 154 (1997) 1277-1284
38. Ilic T.V., Korchounov A., and Ziemann U. Methylphenidate facilitates and disinhibits the motor cortex in intact humans. Neuroreport 14 (2003) 773-776
39. Hoeppner J., Gierow W., Herpertz S., Haessler F., and Buchmann J. Transcranial magnetic stiulation in adults with Attention Deficit-/Hyperactivity Disorder. Eur Arch Psychiatry Clin Neurosci 256 (2006) II/21
40. Biederman J., Faraone S., Milberger S., Curtis S., Chen L., Marrs A., Ouellette C., et al. Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 35 (1996) 343-351
41. Biederman J., Mick E., and Faraone S.V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry 157 (2000) 816-818
42. Porrino L.J., and Lucignani G. Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children. Biol Psychiatry 22 (1987) 126-138
43. Srinivas N.R., Hubbard J.W., Quinn D., and Midha K.K. Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharmacol Ther 52 (1992) 561-568
44. Srinivas N.R., Hubbard J.W., Korchinski E.D., and Midha K.K. Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans. Pharm Res 10 (1993) 14-21
45. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Franceschi D., Maynard L., Ding Y.S., et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse 43 (2002) 181-187
46. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., Hitzemann R., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155 (1998) 1325-1331
47. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., Ding Y., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21 (2001) RC121
48. Federici M., Geracitano R., Bernardi G., and Mercuri N.B. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol Psychiatry 57 (2005) 361-365
49. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., et al. Is methylphenidate like cocaine?. Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52 (1995) 456-463
50. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
51. Garattini S., and Mennini T. Critical notes on the specificity of drugs in the study of metabolism and functions of brain monoamines. Int Rev Neurobiol 29 (1988) 259-280
52. Volkow N.D., Gatley S.J., Fowler J.S., Wang G.J., and Swanson J. Serotonin and the therapeutic effects of ritalin. Science 288 (2000) 11
53. Arnsten A.F., and Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 1 (2005) 2
54. Gao W.J., Krimer L.S., and Goldman-Rakic P.S. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci U S A 98 (2001) 295-300
55. Gao W.J., and Goldman-Rakic P.S. Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proc Natl Acad Sci U S A 100 (2003) 2836-2841
56. Swanson J.M., Sunohara G.A., Kennedy J.L., Regino R., Fineberg E., Wigal T., Lerner M., et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach. Mol Psychiatry 3 (1998) 38-41
57. Hamarman S., Fossella J., Ulger C., Brimacombe M., and Dermody J. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: A pharmacogenetic study. J Child Adolesc Psychopharmacol 14 (2004) 564-574
58. Seeman P., and Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: A hypothesis. Behav Brain Res 130 (2002) 79-83
59. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., and Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381 (1996) 245-248
60. Butefisch C.M., Davis B.C., Sawaki L., Waldvogel D., Classen J., Kopylev L., and Cohen L.G. Modulation of use-dependent plasticity by d-amphetamine. Ann Neurol 51 (2002) 59-68
61. Bares M., Kanovsky P., Klajblova H., and Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: A paired TMS study. Eur J Neurol 10 (2003) 385-389
62. Strafella A.P., Valzania F., Nassetti S.A., Tropeani A., Bisulli A., Santangelo M., and Tassinari C.A. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: A transcranial magnetic stimulation study. Clin Neurophysiol 111 (2000) 1198-1202
63. Ueki Y., Mima T., Kotb M.A., Sawada H., Saiki H., Ikeda A., Begum T., et al. Altered plasticity of the human motor cortex in Parkinson's disease. Ann Neurol 59 (2006) 60-71
64. Sanger T.D., Garg R.R., and Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol 530 (2001) 307-317
65. Daskalakis Z.J., Christensen B.K., Fitzgerald P.B., Roshan L., and Chen R. The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol 543 (2002) 317-326
66. Kalff A.C., de Sonneville L.M., Hurks P.P., Hendriksen J.G., Kroes M., Feron F.J., Steyaert J., et al. Low- and high-level controlled processing in executive motor control tasks in 5-6-year-old children at risk of ADHD. J Child Psychol Psychiatry 44 (2003) 1049-1057
67. Klimkeit E.I., Mattingley J.B., Sheppard D.M., Lee P., and Bradshaw J.L. Motor preparation, motor execution, attention, and executive functions in attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol 11 (2005) 153-173
68. Pitcher T.M., Piek J.P., and Hay D.A. Fine and gross motor ability in males with ADHD. Dev Med Child Neurol 45 (2003) 525-535
69. Tseng M.H., Henderson A., Chow S.M., and Yao G. Relationship between motor proficiency, attention, impulse, and activity in children with ADHD. Dev Med Child Neurol 46 (2004) 381-388
70. Sagvolden T., Johansen E.B., Aase H., and Russell V.A. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28 (2005) 397-419
71. Cao Q., Zang Y., Sun L., Sui M., Long X., Zou Q., and Wang Y. Abnormal neural activity in children with attention deficit hyperactivity disorder: A resting-state functional magnetic resonance imaging study. Neuroreport 17 (2006) 1033-1036